Reduction of Pten dose leads to neoplastic development in multiple organs of Pten (shRNA) mice
Hong Shen-Li1, Susan Koujak, Matthias Szablocs
1Institute for Cancer Genetics, Columbia University Medical Center, New York, NY, USA.
Abstract:
To address the impact of partial reduction of Pten on tumor initiation, we generated PtenshRNA mice, in which PTEN expression was reduced below normal levels in various tissues. PtenshRNA mice frequently developed lymphoid and prostatic hyperplasia, splenomegaly, and sebaceous adenomas. Our observations support the notion that partial reduction of the dose of Pten with shRNA is sufficient to induce neoplastic disease in multiple organ systems.
Insights
Partial reduction of phosphatase and tensin homolog (Pten) using shRNA in mice induced hyperplasia and tumors in multiple organs. This suggests Pten dosage is critical for preventing neoplastic disease across various tissues.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Phosphatase and tensin homolog (Pten) is a tumor suppressor gene.
- Its role in tumor initiation and progression is well-established.
- The impact of partial Pten reduction on tumor development requires further investigation.
Purpose of the Study:
- To investigate the consequences of partial Pten reduction on tumor initiation.
- To determine if reduced Pten levels are sufficient to induce neoplastic disease.
Main Methods:
- Generation of Pten shRNA (short hairpin RNA) transgenic mice.
- Analysis of tumor development in various tissues of these mice.
Main Results:
- Pten shRNA mice exhibited lymphoid and prostatic hyperplasia.
- Splenomegaly and sebaceous adenomas were frequently observed.
- Partial Pten reduction was sufficient to induce neoplastic disease.
Conclusions:
- Partial Pten reduction significantly impacts multiple organ systems.
- Pten dosage is critical for preventing neoplastic disease.
- These findings highlight Pten's role as a crucial tumor suppressor.
More Related Videos
08:36Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses
Published on: October 24, 2019
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Abnormal Proliferation
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Replicative Cell Senescence
